ATE461190T1 - Substituierte pyradinon-derivate als alpha2- adrenorezeptor-antagonisten - Google Patents
Substituierte pyradinon-derivate als alpha2- adrenorezeptor-antagonistenInfo
- Publication number
- ATE461190T1 ATE461190T1 AT06841410T AT06841410T ATE461190T1 AT E461190 T1 ATE461190 T1 AT E461190T1 AT 06841410 T AT06841410 T AT 06841410T AT 06841410 T AT06841410 T AT 06841410T AT E461190 T1 ATE461190 T1 AT E461190T1
- Authority
- AT
- Austria
- Prior art keywords
- disorders
- sub
- anxiety
- pyradinone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05112646 | 2005-12-21 | ||
| PCT/EP2006/069815 WO2007071639A1 (en) | 2005-12-21 | 2006-12-18 | Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE461190T1 true ATE461190T1 (de) | 2010-04-15 |
Family
ID=36353304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06841410T ATE461190T1 (de) | 2005-12-21 | 2006-12-18 | Substituierte pyradinon-derivate als alpha2- adrenorezeptor-antagonisten |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080269251A1 (de) |
| EP (1) | EP1966191B1 (de) |
| JP (1) | JP2009520756A (de) |
| CN (1) | CN101346368A (de) |
| AT (1) | ATE461190T1 (de) |
| AU (1) | AU2006328551A1 (de) |
| CA (1) | CA2626764A1 (de) |
| DE (1) | DE602006013040D1 (de) |
| ES (1) | ES2342116T3 (de) |
| IL (1) | IL192240A0 (de) |
| RU (1) | RU2008129656A (de) |
| WO (1) | WO2007071639A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230109185A (ko) | 2016-06-07 | 2023-07-19 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| TWI664175B (zh) | 2017-03-23 | 2019-07-01 | 大陸商北京加科思新藥研發有限公司 | 用於作為shp2抑制劑之新穎雜環衍生物 |
| CN108178759B (zh) * | 2018-01-05 | 2020-06-09 | 上海瑞纷医药科技有限责任公司 | 一种α-肾上腺素受体拮抗剂的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ527365A (en) * | 2001-02-23 | 2005-08-26 | Merck & Co Inc | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists |
| WO2004067513A1 (en) * | 2003-01-27 | 2004-08-12 | Oy Juvantia Pharma Ltd | Antagonists for alpha-2 adrenoceptors |
-
2006
- 2006-12-18 ES ES06841410T patent/ES2342116T3/es active Active
- 2006-12-18 WO PCT/EP2006/069815 patent/WO2007071639A1/en active Application Filing
- 2006-12-18 AU AU2006328551A patent/AU2006328551A1/en not_active Abandoned
- 2006-12-18 US US12/091,181 patent/US20080269251A1/en not_active Abandoned
- 2006-12-18 CA CA002626764A patent/CA2626764A1/en not_active Abandoned
- 2006-12-18 DE DE602006013040T patent/DE602006013040D1/de active Active
- 2006-12-18 AT AT06841410T patent/ATE461190T1/de not_active IP Right Cessation
- 2006-12-18 EP EP06841410A patent/EP1966191B1/de active Active
- 2006-12-18 JP JP2008546408A patent/JP2009520756A/ja active Pending
- 2006-12-18 RU RU2008129656/04A patent/RU2008129656A/ru not_active Application Discontinuation
- 2006-12-18 CN CNA2006800485538A patent/CN101346368A/zh active Pending
-
2008
- 2008-06-17 IL IL192240A patent/IL192240A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20080269251A1 (en) | 2008-10-30 |
| CA2626764A1 (en) | 2007-06-28 |
| IL192240A0 (en) | 2008-12-29 |
| EP1966191B1 (de) | 2010-03-17 |
| EP1966191A1 (de) | 2008-09-10 |
| RU2008129656A (ru) | 2010-01-27 |
| CN101346368A (zh) | 2009-01-14 |
| WO2007071639A1 (en) | 2007-06-28 |
| AU2006328551A1 (en) | 2007-06-28 |
| DE602006013040D1 (de) | 2010-04-29 |
| JP2009520756A (ja) | 2009-05-28 |
| ES2342116T3 (es) | 2010-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007007472A (es) | Derivados de triazolona, tetrazolona e imidazolona para uso como antagonista del adrenorreceptor alfa-2c. | |
| IL198072A0 (en) | Substituted pyrazinone derivatives for use as a medicine | |
| NO20074961L (no) | Imidazopyridazinforbindelser | |
| CY1112601T1 (el) | Υποκατεστημενα παραγωγα 1-πιπεριδιν-4-υλ-4-πυρρολιδιν-3-υλ-πιπεραζινης και χρηση αυτων ως ανταγωνιστων νευροκινινης | |
| MA32898B1 (fr) | Modulateurs allosteriques positifs du recepteur m1 d'arylmethylbenzoquinazolinone | |
| EA200901162A1 (ru) | Производные 1,4-дизамещённого 3-цианопиридона и их применение в качестве положительных модуляторов рецептора mglur2 | |
| UY28817A1 (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegerativos | |
| ECSP055719A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| MX2009005908A (es) | Derivados novedosos de diaza-espiro-piridinona sustituidos para usarse en las enfermedades mediadas por la hormona concentradora de melanina 1. | |
| NO20071967L (no) | Imidazo-benzodiazepinderivater | |
| PH12019500004A1 (en) | 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases | |
| WO2007135131A8 (en) | Substituted pyrazinone derivatives for use as a medicine | |
| MX2010009643A (es) | Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a). | |
| DE602005016836D1 (de) | Chotischer und anxiolytischer aktivität | |
| ATE461190T1 (de) | Substituierte pyradinon-derivate als alpha2- adrenorezeptor-antagonisten | |
| NO20084819L (no) | Substituerte pyrazinonderivater for anvendelse som en medisin | |
| WO2007035823A3 (en) | Partial mglur5 antagonists and methods of use thereof | |
| HRP20050554B1 (hr) | Supstituirani 1- piperidin-3-il-4-piperidin-4-il-piperazinski derivati i njihova primjena kao neurokininskih antagonista | |
| MX2010009820A (es) | 2-aminoquinolinas como antagonistas del receptor 5-hidroxitriptamina 5a. | |
| ATE440826T1 (de) | Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen | |
| TH80312B (th) | อนุพันธ์ซับสทิทิวเทดไทรแอโซโลน, เททราโซโลน และอิมิแดโซโลน สำหรับใช้เป็นยา | |
| TH80312A (de) | ||
| TH78668A (th) | อนุพันธ์ 1-พิเพอริดิน-4-อิล-4-พิร์โรลิดิน-3-อิล-พิเพอแรซีนที่ถูกแทนที่และการใช้สารเหล่านั้นเป็นแอนทากอนิสท์ของนิวโรไคนิน | |
| TH103570A (th) | 4-(แอริล-x-ฟีนิล)-1h-ไพริดิน-2-โอนซึ่งถูกแทนที่ที่ตำแหน่ง 1,3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |